# OnCo record shanghai-jiatan-pharmatech (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/shanghai-jiatan-pharmatech/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "shanghai-jiatan-pharmatech" ;
  schema:name "Shanghai Jiatan Pharmatech"@en ;
  schema:alternateName "Shanghai Jiatan Pharmatech Co., Ltd"@en ;
  schema:description "Shanghai Jiatan Pharmatech is a China-based biotechnology company that leads 2 cancer trials in OnCo, testing the dual PI3K and mTOR inhibitor WX390 in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/shanghai-jiatan-pharmatech/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?lead=Shanghai%20Jiatan%20Pharmatech%20Co.%2C%20Ltd> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:drugs <https://onco.cc/drugs/toripalimab/> ;
  onco:trials <https://onco.cc/trials/nct06117566/>, <https://onco.cc/trials/nct06117540/> .